Hero image with Pittsburgh background https://pittplusme.org/study/vigilant

STUDY BASICS

Do you have moderate to severe COPD? You may be eligible for a research study to test an investigational drug called depemokimab compared to placebo as an add-on treatment for moderate to severe COPD, given as an injection. Study participation is expected to last 1-3 years during which there will be, on average, about one visit per month. Compensation is provided.


STUDY PURPOSE

This study is being done to test if depemokimab, compared to a placebo or an inactive substance, can improve COPD, make you feel better, is safe, well-tolerated, and works. The investigational medication is given in the form of a shot just under the skin.


COULD THIS STUDY BE RIGHT FOR YOU?

  • Are 40 to 75 years old  

  • Have moderate to severe COPD 

  • Are a current OR former smoker 

  • Have had exactly one exacerbation (symptom flare-up) in the past 12 months that meet certain requirements 

  • Have elevated levels of certain blood cells, known as eosinophils (E-O-SIN-O-FILS) that are known to be higher in some people who have COPD. 


WHAT PARTICIPANTS CAN EXPECT

Participants will get either:

  • The study drug, depemokimab, or
  • An inactive substance (called a placebo). A placebo is an injection that does not have the active ingredient which may treat COPD.

Length of time in the study will vary by participant but is expected to last 1 to 3 years during which there will be, on average, about one visit per month.


IRB: SSU00333962

- GlaxoSmithKline Research & Development Limited - 224295, A multicenter, randomized, double-blind, parallel group, placebo-controlled study of the efficacy and safety of early depemokimab initiation as add-on treatment in COPD patients with Type 2 inflammation (Pro00089566)

PHONE NUMBER: 1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In

INTERESTED?

Visit https://pittplusme.org/study/vigilant and click on "I'm Interested" or call 1-866-438-8230.


LEARN MORE

PittPlusMe.org
1-866-438-8230
PittPlusMe@pitt.edu
@PittPlusMe
@PittPlusMe